Background For a long time, self-monitoring of blood glucose (SMBG) was widely viewed as
the essential glucose measurement procedure in the therapy of insulin-treated people with …

OBJECTIVE To evaluate long-term glycemic outcomes of continuous glucose monitoring
(CGM) initiation within the first year of type 1 diabetes diagnosis. RESEARCH DESIGN AND …

Continuous glucose monitoring (CGM) is an essential tool for modern diabetes therapy.
Randomized controlled studies have provided evidence that hemoglobin A1c (HbA1c) …

OBJECTIVE Continuous glucose monitoring (CGM) has been found to improve glucose
control in type 1 diabetic patients. We estimated the cost-effectiveness of CGM versus …

Objective: To assess the effect of self-monitoring of blood glucose (SMBG) on glycaemic
control in non-insulin treated patients with type 2 diabetes by means of a systematic review …

ABSTRACT Objective/Methods: Barriers to continuous glucose monitoring (CGM) use
continue to hamper adoption of this valuable technology for the management of diabetes …

OBJECTIVE The aim of this trial was to compare the efficacy of real-time and intermittently
scanned continuous glucose monitoring (rtCGM and isCGM, respectively) in maintaining …

OBJECTIVE International type 1 diabetes registries have shown that HbA1c levels are
highest in young people with type 1 diabetes; however, improving their glycemic control …

Background: Our systematic review and meta-analysis of the benefit of self-monitoring of
blood glucose (SMBG) in improving glycemic control in type 2 diabetes was published in …

Background Self‐monitoring of blood glucose is essential to optimise glycaemic control in
type 1 diabetes mellitus. Continuous glucose monitoring (CGM) systems measure interstitial …